865 research outputs found

    Study of noise reduction characteristics of composite fiber-reinforced panels, interior panel configurations, and the application of the tuned damper concept

    Get PDF
    The application of fiber reinforced composite materials, such as graphite epoxy and Kevlar, for secondary or primary structures developing in the commercial airplane industry was investigated. A composite panel program was initiated to study the effects of some of the parameters that affect noise reduction of these panels. The fiber materials and the ply orientation were chosen to be variables in the test program. It was found that increasing the damping characteristics of a structural panel will reduce the vibration amplitudes at resonant frequencies with attendant reductions in sound reduction. Test results for a dynamic absorber, a tuned damper, are presented and evaluated

    The effect of oblique angle of sound incidence, realistic edge conditions, curvature and in-plane panel stresses on the noise reduction characteristics of general aviation type panels

    Get PDF
    Experiments and a theoretical analysis were conducted to predict the noise reduction of inclined and curved panels. These predictions are compared to the experimental results with reasonable agreement between theory and experiment for panels under an oblique angle of sound incidence. Theoretical as well as experimental results indicate a big increase in noise reduction when a flat test panel is curved. Further curving the panel slightly decreases the noise reduction. Riveted flat panels are shown to give a higher noise reduction in the stiffness-controlled frequency region, while bonded panels are superior in this region when the test panel is curved. Experimentally measured noise reduction characteristics of flat aluminum panels with uniaxial in-plane stresses are presented and discussed. These test results indicate an important improvement in the noise reduction of these panels in the frequency range below the fundamental panel/cavity frequency

    Sonography for hip joint effusion in adults with hip pain

    Get PDF
    OBJECTIVE: To study the prevalence of ultrasonic hip joint effusion and its relation with clinical, radiological and laboratory (ESR) findings in adults with hip pain. METHODS: Patients (n = 224) aged 50 years or older with hip pain, referred by the general practitioner for radiological investigation, underwent a standardised examination. The distance between the ventral capsule and the femoral neck, an increase in which represents joint effusion, was measured sonographically. Joint effusion was defined in three different ways: "effusion" according to Koski's definition, "major effusion", and "asymmetrical effusion" based on only individual side differences. RESULTS: "Effusion" was present in 80 (38%), "major effusion" in 20 (9%), and "asymmetrical effusion" in 47 (22%) patients. Pain in the groin or medial thigh, pain aggravated by lying on the side, decreased extension/internal rotation/abduction/flexion, painful external rotation, and pain on palpation in the groin showed a significant relation (adjusted for age and radiological osteoarthritis of the hip) with ultrasonic hip joint effusion. "Major effusion" showed a significant relation with an increased ESR. When patients with bilateral pain and increased ESR were excluded, a side difference in the range of motion of extension of the hip was shown to be a good predictor for "asymmetrical effusion" (positive predictive value: 71%, negative predictive value: 80%). CONCLUSION: This study showed a relatively high prevalence of ultrasonic joint effusion in adults with hip pain in general practice. Furthermore the results indicate a relation between joint effusion and clinical signs

    Міжнародне співробітництво МВС України у сфері протидії корупції

    Get PDF
    У статті здійснено аналіз розвитку та сучасного стану міжнародної співпраці МВС України у сфері протидії корупції. Розглянуто формування нормативно-правової бази щодо боротьби з корупцією та пов’язаною з нею злочинністю, надано характеристику напрямів та шляхів співпраці органів внутрішніх справ нашої країни з іноземними державами, їх правоохоронними органами і спеціальними службами, а також із міжнародними організаціями, які здійснюють заходи із протидії корупції. Визначено перспективи подальшого розвитку міжнародного співробітництва МВС у протидії транснаціональним формам корупції.В статье осуществлен анализ развития и современного состояния международного сотрудничества МВД Украины в сфере противодействия коррупции. Рассмотрено формирование нормативно-правовой базы по борьбе с коррупцией и связанной с ней преступностью, дана характеристика направлений и путей сотрудничества органов внутренних дел Украины с зарубежными государствами, их правоохранительными органами и специальными службами, а также с международными организациями, которые осуществляют мероприятия по противодействию коррупции. Определены перспективные направления дальнейшего развития международного сотрудничества МВД Украины в сфере противодействия транснациональным формам коррупции.Development and modern state of the international cooperation of the Ukranian Ministry of Internal Affairs in the sphere of corruption counteraction is analyzed. It is considered the formation of normative and legal base concerning struggle against corruption and the criminality, it is given the characteristic of directions and ways of cooperation of law-enforcement bodies of Ukraine with the foreign states, their law enforcement bodies and special services, and also with the international organizations which carry out measures on counteraction of corruption. It is determined the perspective directions of the further development of the international cooperation of the Ministry of Internal Affairs in Ukraine in the sphere of counteraction to transnational forms of corruption

    Endoanal MRI of the anal sphincter complex: correlation with cross-sectional anatomy and histology

    Get PDF
    The purpose of this study was to correlate the in vivo endoanal MRI findings of the anal sphincter with the cross-sectional anatomy and histology. Fourteen patients with rectal tumours were examined with a rigid endoanal MR coil before undergoing abdominoperineal resection. In addition, 12 cadavers were used to obtain cross-sectional anatomical sections. The images were correlated with the histology and anatomy of the resected rectal specimens as well as with the cross-sectional anatomical sections of the 12 cadavers. The findings in 8 patients, 11 rectal preparations, and 10 cadavers, could be compared. In these cases, there was an excellent correlation between endoanal MRI and the cross-sectional cadaver anatomy and histology. With endoanal MRI, all muscle layers of the anal canal wall, comprising the internal anal sphincter, longitudinal muscle, the external anal sphincter and the puborectalis muscle wer

    CD1d-specific single-domain antibodies for unconventional immunomodulation

    Get PDF
    Bispecific T cell engagers (bsTCEs) in clinical development and/or (recently) approved as standard of care, face challenges related to the bsTCE format (e.g half-life, tumor penetration, immunogenicity, stability) and targeted effector cells population, as CD3-directed bsTCE recruit T cell populations that either disproportionally contribute to toxicity or actively suppress efficacy. Development of next-generation bsTCE with an improved therapeutic window is therefore needed. This thesis describes the generation of a panel of CD1d specific VHH that differentially impact the CD1d-NKT cell axis and demonstrate that linkage of one specific anti-CD1d VHH with an anti-Vδ2 VHH resulted in a bsTCE with trispecific properties that engages type 1 NKT and Vγ9Vδ2-T cells to CD1d+ tumors. In chapter 2 we give a detailed description of a an efficient method to culture and expand type 1 NKT cells. In chapter 3 we describe the generation of 21 CD1d-specific VHHs via immunization of Lama glama, phage library construction, and selection of CD1d-specific clones. Functional evaluation of these CD1d-specific VHHs resulted in the identification of two VHHs able to induce maturation of dendritic cells, one VHH (VHH1D17) that enhanced annexin V binding (suggestive of early apoptosis) upon binding to CD1d+ malignant hematologic cells, and yet another VHH (VHH1D22) that inhibited activation of type 1 NKT cells by glycolipid-loaded CD1d. In chapter 4 we demonstrate that VHH1D17 mediated induction of annexin V binding on CD1d+ malignant hematologic cells is not reflective of early cell death but results from enhanced presentation of phosphatidylserine (PS) in CD1d. We demonstrate that CD1d(PS) can interact with immune regulatory molecules and induce T-cell immunoglobulin domain and mucin domain (TIM)-3 signaling on effector cells suggesting the existence of a functional CD1d(PS)-TIM-3-axis. In chapter 5 the ability of anti-CD1d VHH1D12 to trigger type 1 NKT cell activation is described. By using a structural and functional approach we demonstrate that VHH1D12 specifically stabilizes the human CD1d-type 1 NKT-TCR interaction and blocks (pro-tumor) diverse NKT cells, which translates directly into effective anti-tumor activity. In chapter 6, this anti-CD1d VHH1D12 is linked to a Vδ2-TCR-specific VHH to generate the CD1d-Vδ2 bsTCE. We subsequently demonstrate robust proinflammatory cytokine production, type 1 NKT and Vγ9Vδ2-T cell expansion, and anti-tumor activity to patient-derived MM, AML and CLL cells and in in vivo mouse models. Exploratory toxicology studies with a fully cross-reactive (surrogate) CD1d-γδ bsTCE in non-human primates (NHP) demonstrated good tolerability, and only low levels of the CRS related cytokine IL-6. Based on these results the CD1d-Vδ2 bsTCE (LAVA-051) is now evaluated in a phase 1/2a study in patients with therapy refractory CLL, MM, or AML (ClinicalTrials.gov Identifier: NCT04887259). In chapter 7 our findings are discussed in the context of the current state of the research field as well as prospects for future research

    Exogenous angiotensin II does not facilitate norepinephrine release in the heart

    Get PDF
    Studies on the effect of angiotensin II on norepinephrine release from sympathetic nerve terminals through stimulation of presynaptic angiotensin II type 1 receptors are equivocal. Furthermore, evidence that angiotensin II activates the cardiac sympathetic nervous system in vivo is scarce or indirect. In the intact porcine heart, we investigated whether angiotensin II increases norepinephrine concentrations in the myocardial interstitial fluid (NE(MIF)) under basal conditions and during sympathetic activation and whether it enhances exocytotic and nonexocytotic ischemia-induced norepinephrine release. In 27 anesthetized pigs, NE(MIF) was measured in the left ventricular myocardium using the microdialysis technique. Local infusion of angiotensin II into the left anterior descending coronary artery (LAD) at consecutive rates of 0.05, 0.5, and 5 ng/kg per minute did not affect NE(MIF), LAD flow, left ventricular dP/dt(max), and arterial pressure despite large increments in coronary arterial and venous angiotensin II concentrations. In the presence of neuronal reuptake inhibition and alpha-adrenergic receptor blockade, left stellate ganglion stimulation increased NE(MIF) from 2.7+/-0.3 to 7.3+/-1.2 before, and from 2.3+/-0.4 to 6.9+/-1.3 nmol/L during, infusion of 0.5 ng/kg per minute angiotensin II. Sixty minutes of 70% LAD flow reduction caused a progressive increase in NE(MIF) from 0.9+/-0.1 to 16+/-6 nmol/L, which was not enhanced by concomitant infusion of 0.5 ng/kg per minute angiotensin II. In conclusion, we did not observe any facilitation of cardiac norepinephrine release by angiotensin II under basal conditions and during either physiological (ganglion stimulation) or pathophysiological (acute ischemia) sympathetic activation. Hence, angiotensin II is not a local mediator of cardiac sympathetic activity in the in vivo porcine heart

    Cardioprotection in pigs by exogenous norepinephrine but not by cerebral ischemia-induced release of endogenous norepinephrine

    Get PDF
    BACKGROUND AND PURPOSE: Endogenous norepinephrine release induced by cerebral ischemia may lead to small areas of necrosis in normal hearts. Conversely, norepinephrine may be one of the mediators that limit myocardial infarct size by ischemic preconditioning. Because brief ischemia in kidneys or skeletal muscle limits infarct size produced by coronary artery occlusion, we investigated whether cardiac norepinephrine release during transient cerebral ischemia also elicits remote myocardial preconditioning. METHODS: Forty-one crossbred pigs of either sex were assigned to 1 of 7 experimental groups, of which in 6 groups myocardial infarct size was determined after a 60-minute coronary occlusion and 12
    corecore